EMA — authorised 20 August 2021
- Marketing authorisation holder: UCB Pharma S.A.
- Status: approved
🇪🇺 Bimzelx in European Union
EMA authorised Bimzelx on 20 August 2021
Marketing authorisation
Bimzelx in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Bimzelx approved in European Union?
Yes. EMA authorised it on 20 August 2021.
Who is the marketing authorisation holder for Bimzelx in European Union?
UCB Pharma S.A. holds the EU marketing authorisation.